Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess the efficacy and tolerability of memantine
(anti-excitotoxic, neuroprotective treatment currently used in Alzheimer's disease [AD]) in
frontotemporal dementia patients after a one-year treatment.